Wednesday, April 22

Browsing: Cabazitaxel

Support

Cabazitaxel Combo Does Not Significantly Improve Prostate Cancer Survival

By NewsCancerFebruary 28, 20260

Findings from the phase 3 PEACE-2 trial (NCT01952223) showed no significant improvement in progression-free survival (PFS), overall survival (OS), and…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

AACR in 30 Seconds: Revolution Medicines data, NCI director, wildfires

HDAC8 inhibition targets STAT3–MYC axis and synergizes with Venetoclax in KMT2A-rearranged acute myeloid leukemia

Mastectomy, ET Linked to Lower LRR in Young Populations With Breast Cancer

Browsing: Cabazitaxel

Cabazitaxel Combo Does Not Significantly Improve Prostate Cancer Survival

AACR in 30 Seconds: Revolution Medicines data, NCI director, wildfires

HDAC8 inhibition targets STAT3–MYC axis and synergizes with Venetoclax in KMT2A-rearranged acute myeloid leukemia

Mastectomy, ET Linked to Lower LRR in Young Populations With Breast Cancer

Revolution Medicines previews ‘novel class’ of cancer treatments

AACR in 30 Seconds: Revolution Medicines data, NCI director, wildfires

HDAC8 inhibition targets STAT3–MYC axis and synergizes with Venetoclax in KMT2A-rearranged acute myeloid leukemia

Mastectomy, ET Linked to Lower LRR in Young Populations With Breast Cancer

Revolution Medicines previews ‘novel class’ of cancer treatments

Latest Post

AACR in 30 Seconds: Revolution Medicines data, NCI director, wildfires

HDAC8 inhibition targets STAT3–MYC axis and synergizes with Venetoclax in KMT2A-rearranged acute myeloid leukemia

Mastectomy, ET Linked to Lower LRR in Young Populations With Breast Cancer

Subscribe to Updates

What's Hot

Browsing: Cabazitaxel